Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.
Sec. Clinical Nutrition
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1384145

Efficacy of a New Immunonutrition Formula with Extra Virgin Olive Oil in the Reduction of Complications in Surgeries of Upper Digestive Tract Tumours Provisionally Accepted

Rocío Villar Taibo1  Alfonso Vidal Casariego2* Alicia Santamaría Nieto1 Ana Cantón Blanco1  Ana B. Crujeiras3, 4 Gloria Lugo Rodríguez5 Gemma Rodríguez Carnero1 Francisco Pita Gutiérrez5  Antia Fernandez-Pombo1 Everardo Díaz López1 Andrea Roman Eyo1  Uxía Rodríguez Lavandeira5  Alberto Pena Dubra1  Miguel Á. Martínez Olmos1, 4
  • 1Department of Endocrinology and Nutrition, University Hospital Complex of Santiago, Spain
  • 2Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de A Coruña,, Spain
  • 3Unidad de Epigenómica, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Spain
  • 4CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN), Spain
  • 5Department of Endocrinology and Nutrition, Biomedical Research Institute Complejo Hospitalario Universitario de A Coruña, Spain

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Background: to demonstrate whether a nutritional supplement enriched with arginine, nucleotides, omega-3 fatty acids, and extra virgin olive oil reduces postoperative complications in patients with tumours in the upper digestive tract. Methods: a randomised, controlled, double-blind, multicentre clinical trial, in which a new immunomodulatory formula with extra virgin olive oil was compared with a standard isoprotein and isoenergetic formula. Patients with gastric, esophageal or biliopancreatic tumours were recruited to receive two units of immunomodulatory formula or control, five days before the surgical intervention. Results: 119 patients were recruited. There was a significant reduction in the number of reinterventions (7.7 vs. 20.4%; p = 0.044) in the intervention group. There was a significant reduction in the development of fistulas in patients with phase angles >5.7º. Also, there were fewer readmissions after biliopancreatic surgeries (0.0 vs. 100%; p = 0.014). The length of hospital stay was similar between groups; however, with the immunomodulatory formula, the patients exhibited greater phase angles at the end of follow-up. Conclusions: the immunomodulatory formula with extra virgin Con formato: Español (España) 2 olive oil administered five days before surgery for stomach, esophageal and biliopancreatic tumours improved cellular health and reduced postoperative complications.

Keywords: Immunonutrition, Arginine, Omega-3 fatty Acids, extra virgin olive oil, Surgery, Cancer

Received: 08 Feb 2024; Accepted: 10 May 2024.

Copyright: © 2024 Villar Taibo, Vidal Casariego, Santamaría Nieto, Cantón Blanco, Crujeiras, Lugo Rodríguez, Rodríguez Carnero, Pita Gutiérrez, Fernandez-Pombo, Díaz López, Roman Eyo, Rodríguez Lavandeira, Pena Dubra and Martínez Olmos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Alfonso Vidal Casariego, Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de A Coruña,, A Coruña, Spain